A Case Report of Cardiogenic Syncope Due to Loperamide Abuse: Acute Presentation and Novel Use of Buprenorphine

Autor: David J. Betting, James A. Chenoweth, Angela F. Jarman

Publikováno v: Clinical Practice and Cases in Emergency Medicine, Vol 5, Iss 2 (2021)

Introduction: Loperamide is a non-prescription anti-diarrheal agent targeting μ-opioid receptors in the intestinal tract. At high doses it crosses the blood-brain barrier, where μ-opioid agonism can cause euphoric effects. Misuse has been increasin

Externí odkaz: https://doaj.org/article/2966abf1b3324ce38e42fec24eb4c8e0

Supplementary Methods, Table 1 from Programmed Death Ligand 1 Is Expressed by Non–Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells

Autor: John M. Timmerman, David J. Betting, Geraldine S. Pinkus, Jonathan Said, Reiko E. Yamada, David J. Andorsky

PDF file - 124K

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::501f43e9827bca9bf4a8251ddc4c6551
https://doi.org/10.1158/1078-0432.22442490.v1

Supplementary Figures 1-7, Tables 1-4 from Analysis of Fcγ Receptor IIIa and IIa Polymorphisms: Lack of Correlation with Outcome in Trastuzumab-Treated Breast Cancer Patients

Autor: John M. Timmerman, Dennis J. Slamon, Omkar Marathe, Valerie Bee, Miguel Martin, Wolfgang Eiermann, Tadeusz Pienkowski, Adam Brufsky, Carla Falkson, John Crown, Vicente Valero, Nicholas J. Robert, Mark X. Sliwkowski, Sambasivarao Damaraju, Adrian Driga, John Mackey, Marc Buyse, Ying Zhao, Somasekar Seshagiri, Jeremy Stinson, Emmanuel Quinaux, Howard M. Stern, David J. Betting, Sara A. Hurvitz

PDF file - 507K, Supplemental Table 1A: PCR and Sanger Sequencing Primers Supplemental Table 1B: PCR and Sequenom Genotyping Primers Supplemental Figure 1. Kaplan-Meier estimates of disease free survival for BCIRG 006 study, entire population, third

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58f2b4ecd166fdf6937eb5cfca203e4a
https://doi.org/10.1158/1078-0432.22443573

A Case Report of Cardiogenic Syncope Due to Loperamide Abuse: Acute Presentation and Novel Use of Buprenorphine

Autor: James A. Chenoweth, Angela F. Jarman, David J Betting

Publikováno v: Clinical Practice and Cases in Emergency Medicine, Vol 5, Iss 2 (2021)
Clinical Practice and Cases in Emergency Medicine

Author(s): Betting, David J.; Chenoweth, James A.; Jarman, Angela F. | Abstract: Introduction: Loperamide is a non-prescription anti-diarrheal agent targeting µ-opioid receptors in the intestinal tract. At high doses it crosses the blood-brain barri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f35023327f075ce5e710fb1b02f68fd
https://escholarship.org/uc/item/3459j48q

Combination of Cyclophosphamide, Rituximab, and Intratumoral CpG Oligodeoxynucleotide Successfully Eradicates Established B cell Lymphoma

Autor: Sara A. Hurvitz, Kamran Kafi, Nico van Rooijen, David J. Betting, Reiko E. Yamada, Kristopher K Steward, John M. Timmerman

Publikováno v: Journal of Immunotherapy, 35(7), 534-543. Lippincott Williams and Wilkins
Betting, D J, Hurvitz, S A, Steward, K K, Yamada, R E, Kafi, K, van Rooijen, N & Timmerman, J M 2012, ' Combination of Cyclophosphamide, Rituximab, and Intratumoral CpG Oligodeoxynucleotide Successfully Eradicates Established B cell Lymphoma ', Journal of Immunotherapy, vol. 35, no. 7, pp. 534-543 . https://doi.org/10.1097/CJI.0b013e318261e679

Rituximab plus chemotherapy is standard therapy for patients with non-Hodgkin B cell lymphoma, but often complete response or cure is not achieved. Toll-like receptor 9 agonist CpG oligodeoxynucleotides (CpG) can improve antibody-dependent cellular c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d69800e53c0129ae41e0767888cd75f
https://doi.org/10.1097/cji.0b013e318261e679